Clinical Trial Update: Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome

View source ↗

Summary

This update reports the completion of a clinical trial investigating gut peptides and intestinal permeability in individuals with celiac disease and irritable b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease
• Irritable Bowel Syndrome

Snippet

Sponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis | Conditions: Celiac Disease, Irritable Bowel Syndrome | Status: COMPLETED